Home › Funds › Kiltearn Partners LLP › HCA
Kiltearn Partners LLP position in HCA
HCA HEALTHCARE INC · Health Care
Kiltearn Partners LLP reported holding 42,019 shares of HCA (HCA HEALTHCARE INC) in its Q3 2026 13F filing — a position valued at US$17.9M, representing 4.32% of its reported portfolio and ranking #8 among its reported holdings. Kiltearn Partners LLP has disclosed HCA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Kiltearn Partners LLP's HCA position evolved
Kiltearn Partners LLP first disclosed a stake in HCA in Q3 2023 at 147,700 shares (US$36.3M). The position peaked in Q4 2023 at 172,300 shares, worth US$46.6M. Across 13 filings, Kiltearn Partners LLP increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 42,019 shares valued at US$17.9M — an increase of 4,705 shares quarter over quarter.. Notable position changes include a 37% trim in Q2 2024 (shares rose 26% over the following quarter), a 38% trim in Q3 2024 (shares fell 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 147.70K | $36.33M | New |
| Q4 2023 | 172.30K | $46.64M | Add |
| Q1 2024 | 140.00K | $46.22M | Reduce |
| Q2 2024 | 88.10K | $28.30M | Reduce |
| Q3 2024 | 54.80K | $22.27M | Reduce |
| Q4 2024 | 49.70K | $14.92M | Reduce |
| Q1 2025 | 42.70K | $14.75M | Reduce |
| Q2 2025 | 39.50K | $15.13M | Reduce |
| Q3 2025 | 42.70K | $18.20M | Add |
| Q4 2025 | 35.80K | $16.71M | Reduce |
| Q1 2026 | 30.00K | $14.20M | Reduce |
| Q2 2026 | 37.31K | $14.55M | Add |
| Q3 2026 | 42.02K | $17.93M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HCA and 13F data
HCA (HCA HEALTHCARE INC) is a Health Care company. 24 other funds we track also report a position in HCA — the largest reported positions include Sanders Capital, LLC (US$3.75B), First Eagle Investment Management (US$1.39B), Arrowstreet Capital (US$851.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HCA
- Sanders Capital, LLC 8.79M sh · $3.75B · Q3 2026
- First Eagle Investment Management 3.27M sh · $1.39B · Q3 2026
- Arrowstreet Capital 2.00M sh · $851.78M · Q3 2026
- NORDEA INVESTMENT MANAGEMENT AB 1.40M sh · $602.17M · Q3 2026
More on Kiltearn Partners LLP
FAQ
How long has Kiltearn Partners LLP held HCA?
Kiltearn Partners LLP has disclosed HCA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Kiltearn Partners LLP's current position in HCA?
As of Q3 2026, Kiltearn Partners LLP holds 42.02K shares of HCA (HCA HEALTHCARE INC), valued at $17.93M, representing 4.32% of its reported portfolio and ranking #8.
Has Kiltearn Partners LLP been buying or selling HCA?
In the latest 13F filing (Q3 2026), Kiltearn Partners LLP increased its position in HCA. The position peaked in Q4 2023 at 172.30K shares.
Which other funds hold HCA?
Other major institutional holders of HCA include Sanders Capital, LLC, First Eagle Investment Management, Arrowstreet Capital, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.